by | Jul 1, 2024 | Publications
Imaging Sci Dent. 2024 Jun;54(2):211-220. doi: 10.5624/isd.20230257. Epub 2024 Apr 1. ABSTRACT Non-secretory multiple myeloma (NSMM) is a rare cancer of plasma cells characterized by the absence of detectable monoclonal M protein in the blood or urine. A 57-year-old...
by | Jun 30, 2024 | Publications
Mymensingh Med J. 2024 Jul;33(3):840-847. ABSTRACT Multiple myeloma (MM), mature B-cell lineage neoplasm, is characterized by abnormal clonal proliferation of plasma cells and presence of monoclonal protein (M protein). The study was conducted to reveal presenting...
by | Jun 29, 2024 | Publications
Am J Hematol. 2024 Jun 28. doi: 10.1002/ajh.27422. Online ahead of print. ABSTRACT DISEASE OVERVIEW: Multiple myeloma accounts for approximately 10% of hematologic malignancies. DIAGNOSIS: The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven...
by | Jun 29, 2024 | Publications
Nat Cancer. 2024 Jun 28. doi: 10.1038/s43018-024-00784-3. Online ahead of print. ABSTRACT Multiple myeloma (MM) is a plasma cell malignancy of the bone marrow. Despite therapeutic advances, MM remains incurable, and better risk stratification as well as new therapies...
by | Jun 29, 2024 | Publications
Ann Hematol. 2024 Jun 28. doi: 10.1007/s00277-024-05860-3. Online ahead of print. ABSTRACT Multiple myeloma (MM) is a form of clonal plasma cell malignancy that associates with clinical manifestations such as anemia, hypercalcemia, bone pain, and renal impairment....
by | Jun 29, 2024 | Publications
Crit Rev Oncol Hematol. 2024 Jun 26:104429. doi: 10.1016/j.critrevonc.2024.104429. Online ahead of print. ABSTRACT In the intricate landscape of multiple myeloma, a hematologic malignancy of plasma cells, bone disease presents a pivotal and often debilitating...
